Prescription Drug Monitoring Program

In February 2016, the Nebraska Legislature passed LB 471, a bill to improve Nebraska's PDMP, or Prescription Drug Monitoring Program. The program will operate through Nebraska's Health Information Exchange (HIE), otherwise known as the Nebraska Health Information Initiative or NeHII. 

LB 471, which will begin January 1, 2017, requires that all controlled substances dispensed in Nebraska be reported to the PDMP.

Requirements include: 

  • Required daily reporting of all dispensed controlled substances by:
  • ·         all Nebraska pharmacies and
  • ·         all mail service pharmacies dispensing to an address in Nebraska,
  • Preventing patients from opting out of the PDMP, and
  • Providing access to prescribers and dispensers at no cost. 

Prescribers, dispensers, and dispenser’s designees will need to register to access and view PDMP data. Providers will need to complete the PDMP User Access Request Form and submit it to NeHII at Please note: if you are a prescriber or dispenser and a NeHII Health Information Exchange (HIE) participant, NeHII staff will automatically enroll you for access to the PDMP.  

Educational Opportunities from the NMA: 

Opioid Abuse and The PDMP
May 10 - noon
Presented by Jane Theobald, MD and Kevin Borcher, Pharm.D

Pain Management
July 19 - noon
Presented by John Massey, MD


LB 471
Opioid resources master list
Nebraska Prescription Drug Monitoring Program website

Nebraska Medical Association magazine on the PDMP
PDMP implementation guide (updated January 19, 2017)

If you have questions regarding the PDMP registration process, contact Kevin Borcher, PDMP Director, NeHII, at or

If you have general questions pertaining to the PDMP or opioid misuse prevention efforts, contact Amy Reynoldson, Prescription Drug Overdose Prevention Coordinator, at or (402) 471-0835.